Ftse Mib
33.948,05
0,95%
DAX
18.160,51
0,93%
S&P 500
5.155,59
0,54%
NASDAQ
16.255,04
0,61%
Bitcoin
63.162,23
-1,31%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Nautilus Biotechnology Inc (NAUT) Nautilus Biotechnology Inc (NAUT) Notizie

Nautilus Biotechnology Inc

NAUT
2,80
0,11 (4,09%)
Ultimo aggiornamento: 16:58:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202414:00GLOBENautilus Biotechnology Reports First Quarter 2024 Financial..
11/4/202414:00GLOBENautilus Biotechnology to Announce First Quarter 2024..
07/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/3/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/3/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:00GLOBENautilus Biotechnology Reports Fourth Quarter and Fiscal..
28/2/202413:26EDGAR2Form 8-K - Current report
28/2/202413:25EDGAR2Form S-3 - Registration statement under Securities Act of..
28/2/202413:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:03EDGAR2Form 8-K - Current report
22/2/202414:00GLOBENautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ..
07/2/202414:00GLOBENautilus Biotechnology to Announce Fourth Quarter and Full..
14/12/202322:17EDGAR2Form 8-K - Current report
30/11/202314:00GLOBENautilus Biotechnology Co-founder and Chief Scientist Parag..
01/11/202313:05GLOBENautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice..
31/10/202321:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202313:05GLOBENautilus Biotechnology Reports Third Quarter 2023 Financial..
11/10/202314:05GLOBENautilus Biotechnology to Announce Third Quarter Financial..
06/9/202313:30GLOBENautilus Biotechnology to Participate in Upcoming September..
04/8/202314:00GLOBENautilus Biotechnology to Participate in Upcoming August..
02/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:30GLOBENautilus Biotechnology Reports Second Quarter 2023 Financial..
11/7/202315:23GLOBENautilus Biotechnology to Announce Second Quarter Financial..
24/5/202314:05GLOBENautilus Biotechnology to Participate in Upcoming June..
Apertura: 2,71 Min: 2,71 Max: 2,815
Chiusura: 2,69

La tua Cronologia

NASDAQ
NAUT
Nautilus Biotechnology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network